Clinical trial
Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related…
NCT00108433 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00108433 |
|---|---|
| Title | Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections |
| Official title | Linezolid vs Vancomycin/Cefazolin in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bacteremia, Gram-Positive Bacterial Infections |
| Intervention type | Drug |
| Interventions | Cefazolin IV, Linezolid IV, Vancomycin (IV) |
| Enrollment | 61 |
| Start date | Sep 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Apr 18, 2005 |
| Last update posted | Aug 7, 2012 |
| Countries | Colombia, India, Israel, Italy, Poland, Slovakia, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: